Occasionally, we see objections to antiviral drugs, especially those targeting broad spectrum efficacy, based on the idea that viruses can be beneficial to human life. Usually however, these objections rest on a straw man: including viruses which attack bacteria (known…
Before covid-19 burst into our lives and onto our screens in 2019, the word ‘pandemic’ was not part of the daily vocabulary. It’s quite possible that I’ve never even used the word during my 46 years on this planet. Now,…
In this article we will answer some of the questions we get asked about our work. If you have a question you’d like answered, please email us. The most recent updates are added to the bottom of the article, and…
Media Release – 28 November 2022 Nelson biotech company Kimer Med is expanding into a new laboratory and looking to hire additional staff after signing an agreement with Cawthron Institute this week. The move means Kimer Med will now be…
The current monkeypox outbreak continues to cause concern, not least because there are no specific antivirals to treat this infection. As attention turns to rapidly repurposing other drugs in the hope that they might prove to be effective, the situation…
More than 3,000 people die every day from liver disease caused by viral hepatitis, and today (July 28) is World Hepatitis Day. What is World Hepatitis Day? World Hepatitis Day is an annual opportunity to raise awareness about the suffering…
We are thrilled to receive this significant support in the form of R&D funding, and see it as recognition of the important science that we are undertaking. Media Release – 06 July 2022 Nelson biotech start-up Kimer Med has been…
There’s been a huge amount of interest in and discussion about vaccines over the past couple of years, and more than 66% of the world’s population has now received at least one dose of a Covid-19 vaccine1. Vaccines are designed…